Xeris Pharmaceuticals (XERS) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Xeris Pharmaceuticals (XERS) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Xeris Pharmaceuticals

· XERS

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

1.655 B

+11.56%

General

Market Cap: $1.66B
Enterprise Value: $1.92B
Shares Outstanding: 172,640,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 83.34%
Operating Margin: 10.91%
Net Profit Margin: -5.12%
FCF Margin: 16.51%
ROA: -4.17%
ROE: -426.33%
ROIC: 12.51%
Current Ratio: 1.45
Debt-to-Equity: -29.74
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 5.21
P/FCF: 31.58
P/B: —
EV/EBITDA: 116.77

Growth

Rev 1Y: 43.72%
Rev 1Y Fwd Est: 32.77%
Rev 3Y (CAGR): 38.33%
Rev 5Y (CAGR): 70.20%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: -1287.50%
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $335.41M
Gross Margin: 83.34%
Operating Expenses: $242.95M
Operating Income: $36.59M
Net Profit: -$17.17M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $121.75M
Working Capital: $85.19M
Total Assets: $411.91M
Net Debt: $167.7M
Total Liabilities: $421.64M
Total Equity: -$9.73M

Cash Flow Statement (TTM)

Cash Flow from Operations: $56.61M
Cash Flow from Investing: -$938K
Cash Flow from Financing: $6.69M
Free Cash Flow: $55.38M
Capital Expenditures: $1.23M